# Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

> **NCT02593071** · PHASE2 · COMPLETED · sponsor: **Novavax** · enrollment: 1330 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** RSV-F Vaccine
- **BIOLOGICAL:** Phosphate Buffer Placebo

## Key facts

- **NCT ID:** NCT02593071
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 1330 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593071, "Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02593071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*